相关实验视频
Updated: Jun 27, 2025
04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
254
探索在急性情况下使用来治疗自杀倾向:理由,风险和不确定性
Rafael Ramos Amaral1, Pedro V S Magalhães2
1Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Trends in psychiatry and psychotherapy
|April 30, 2024
概括
对于长期预防自杀是有效的,但对快速抗抑郁作用的证据有限. 对副作用和延迟治疗水平的担忧超过了对急性自杀倾向的潜在短期益处.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 是一种成熟的情绪稳定剂,在预防自杀方面已被证明具有长期的有效性.
- 具有迅速施加抗自杀作用的潜力仍然是临床兴趣的领域.
- 目前,有限的证据支持对自杀倾向的急性疗效.
研究的目的:
- 为了评估快速抗自杀作用的证据.
- 权衡潜在的短期益处与已知的风险和治疗的局限性.
- 为了澄清在治疗急性自杀倾向中的作用.
主要方法:
- 关于对自杀倾向的急性影响的现有文献的审查.
- 对临床数据分析关于的副作用概况和治疗水平的时间.
- 考虑衡量自杀倾向的短期结果的复杂性.
主要成果:
- 目前对的快速抗自杀功效的证据有限.
- 显著的担忧包括的副作用 (毒性,功能障碍,体重增加) 和延迟治疗开始.
- 将对自杀念头的特定影响与整体抑郁症症状减轻分开是具有挑战性的.
结论:
- 作为急性自杀倾向的快速起作用剂的常规使用,目前的证据并不充分支持.
- 在紧急情况下,可能对特定的高风险患者保持价值.
- 需要进一步的研究来澄清在急性自杀危机中的作用.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
176
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176
01:30Electroconvulsive Therapy
37
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
37
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:30Psychosurgery
54
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
54
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:26Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124